These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10869312)

  • 1. Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969-1993.
    Bulliard JL; Cox B
    Int J Epidemiol; 2000 Jun; 29(3):416-23. PubMed ID: 10869312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous melanoma.
    Armstrong BK; Kricker A
    Cancer Surv; 1994; 19-20():219-40. PubMed ID: 7534627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
    Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
    Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does relative melanoma distribution by body site 1960-2004 reflect changes in intermittent exposure and intentional tanning in the Swedish population?
    Dal H; Boldemann C; Lindelöf B
    Eur J Dermatol; 2007; 17(5):428-34. PubMed ID: 17673388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of stroke in women in Auckland, New Zealand. Ethnic trends over two decades: 1981-2003.
    Dyall L; Carter K; Bonita R; Anderson C; Feigin V; Kerse N; Brown P;
    N Z Med J; 2006 Nov; 119(1245):U2309. PubMed ID: 17146484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous melanoma mortality starting to change: a study of trends in Northern Ireland.
    Montella A; Gavin A; Middleton R; Autier P; Boniol M
    Eur J Cancer; 2009 Sep; 45(13):2360-6. PubMed ID: 19375307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality from cutaneous melanoma: evidence for contrasting trends between populations.
    Severi G; Giles GG; Robertson C; Boyle P; Autier P
    Br J Cancer; 2000 Jun; 82(11):1887-91. PubMed ID: 10839308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do sex and site matter? Different age distribution in melanoma of the trunk among Swedish men and women.
    Pérez-Gómez B; Aragonés N; Gustavsson P; Lope V; López-Abente G; Pollán M
    Br J Dermatol; 2008 Apr; 158(4):766-72. PubMed ID: 18241261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005.
    Pruthi DK; Guilfoyle R; Nugent Z; Wiseman MC; Demers AA
    J Am Acad Dermatol; 2009 Jul; 61(1):44-50. PubMed ID: 19395122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006.
    Tryggvadóttir L; Gislum M; Hakulinen T; Klint A; Engholm G; Storm HH; Bray F
    Acta Oncol; 2010 Jun; 49(5):665-72. PubMed ID: 20491525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous melanoma in New Zealand: 2000-2004.
    Liang JJ; Robinson E; Martin RC
    ANZ J Surg; 2010 May; 80(5):312-6. PubMed ID: 20557503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Has mortality from malignant melanoma stopped rising in Spain? Analysis of trends between 1975 and 2001.
    Cayuela A; Rodríguez-Domínguez S; Lapetra-Peralta J; Conejo-Mir JS
    Br J Dermatol; 2005 May; 152(5):997-1000. PubMed ID: 15888159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting early detection of malignant melanoma of the skin.
    Cooke KR; McNoe BM
    N Z Med J; 1990 Nov; 103(902):551-3. PubMed ID: 2243650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality trends in cutaneous malignant melanoma in Spain, 1967-1986.
    Pollán M; López-Abente G
    Cancer Epidemiol Biomarkers Prev; 1993; 2(6):545-50. PubMed ID: 8268771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in nonmelanoma skin cancer mortality.
    Cooke K; McNoe B; Sharples K
    N Z Med J; 1991 Oct; 104(922):437-8. PubMed ID: 1923102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved survival for melanoma in Northern Ireland: a comparison of two 5-year periods (1984-88 and 1994-98).
    McMullen EA; Kee F; Patterson CC; Gavin AT; Dolan OM
    Br J Dermatol; 2004 Sep; 151(3):587-93. PubMed ID: 15377344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
    Coory M; Baade P; Aitken J; Smithers M; McLeod GR; Ring I
    Cancer Causes Control; 2006 Feb; 17(1):21-7. PubMed ID: 16411049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer incidence and mortality in France over the period 1978-2000.
    Remontet L; Estève J; Bouvier AM; Grosclaude P; Launoy G; Menegoz F; Exbrayat C; Tretare B; Carli PM; Guizard AV; Troussard X; Bercelli P; Colonna M; Halna JM; Hedelin G; Macé-Lesec'h J; Peng J; Buemi A; Velten M; Jougla E; Arveux P; Le Bodic L; Michel E; Sauvage M; Schvartz C; Faivre J
    Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 1):3-30. PubMed ID: 12684578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The control of melanoma in New Zealand.
    Sneyd M; Cox B
    N Z Med J; 2006 Sep; 119(1242):U2169. PubMed ID: 16998570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Buettner PG; Leiter U; Eigentler TK; Garbe C
    Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.